Bayer today announced leadership changes within its Consumer Health division to accelerate growth, strengthen commercial ...
Bayer (XTRA:BAYN) has received validation from the European Medicines Agency for the marketing application of its oral Factor XIa inhibitor, asundexian, for stroke prevention. Asundexian is also under ...
Contract research organization Hesperos announced the publication of a peer-reviewed study developed in conjunction with Bayer Consumer Health. The study, published in Biomedicine and Pharmacology, ...
Evaluating the effectiveness of a creative ad remains a critical, ongoing consideration for health brands. Improving content quality is more than just an exercise in creative pride, there are ...
WHIPPANY, N.J.--(BUSINESS WIRE)-- One A Day®, the multivitamin and supplement brand by Bayer rooted in 80+ years of nutritional science, today announced a bold new brand identity and positioning ...
MYERSTOWN, Pa.--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This ...
Bayer has selected Interpublic to handle global media, creative and production services for its consumer health division after a formal review, the companies have confirmed. Bayer made a point of ...
Bayer is working with custom algorithm firm Chalice AI and data partner Snowflake to create audiences for targeting ads.
Bayer today announced leadership changes within its Consumer Health division to accelerate growth, strengthen commercial execution, and further enhance speed of decision making. These changes reflect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results